
biocrates life sciences ag
Quantitative metabolomics kits and services for mass spectrometry-based analysis in pharma, academia, and clinical research.
Overview
biocrates is a life sciences company with more than 20 years of experience delivering quantitative, standardized, and reproducible mass spectrometry-based metabolomics solutions. The company provides ready-to-measure kits, innovative software, and comprehensive services that enable scientists in pharma, academia, and health institutions to establish and scale metabolomics workflows within days. biocrates has built a global community of more than 100 core facilities, contract research organizations (CROs), service customers, and kit users, all working to accelerate science through quantitative metabolomics.
As of 2025, biocrates has become part of the Biognosys Group, which delivers high-performance, robust solutions across proteomics, metabolomics, and lipidomics. Building on the combined strengths of PreOmics, Biognosys, and biocrates, the Biognosys Group integrates industry-leading consumables, software, instruments, and CRO services to make advanced mass spectrometry workflows seamless, scalable, and accessible to every laboratory. The group maintains a vendor-neutral strategy, ensuring open and flexible collaboration across the scientific community and broad compatibility across major mass spectrometry platforms.
Targeted Profiling Kits
- MxP Quant 1000 kit — a broad-coverage targeted metabolomics profiling kit for comprehensive metabolite quantification
- LxQuant kit — targeted lipidomics quantification kit
- MxQuant kit — targeted metabolomics quantification kit
- MxP Quant 500 XL — extended targeted metabolomics profiling kit
- MxP Quant 500 — targeted metabolomics profiling kit covering 500 metabolites
- MxP Quant HR Xpress — high-resolution targeted metabolomics kit for rapid workflows
- SMartIDQ alpha kit — targeted metabolomics kit for specialized applications
- AbsoluteIDQ p400 HR — high-resolution absolute quantification kit covering up to 400 metabolites
- AbsoluteIDQ p180 — established absolute quantification kit covering 180 metabolites
Pathway-Specific Kits
- AbsoluteIDQ Bile Acids — a dedicated kit for the targeted quantification of bile acids, enabling focused pathway analysis
Software Solutions
- WebIDQ workflow manager — a software platform for managing and streamlining the end-to-end metabolomics measurement workflow
- MetaboINDICATOR — a tool for generating metabolism indicators to support biological interpretation of metabolomics data
- Quantitative Metabolomics Database (QMDB) — a database resource supporting quantitative metabolomics data management and reference
Services
- Metabolomics phenotyping — full-service sample measurement and metabolic profiling from study design consulting through to sample analysis
- Data analysis and biostatistics — expert statistical analysis and interpretation of metabolomics datasets
- Pathway analysis — biological pathway-level interpretation of metabolomics results
- Multiomics data analysis — integrated analysis combining metabolomics with other omics data layers for deeper biological insights
- Support — technical and scientific support for kit users and service customers
Application Areas
- 5P medicine — supporting predictive, preventive, personalized, participatory, and precision medicine approaches
- Pharmacometabolomics — metabolomics applications in drug development and pharmacological research
- Epidemiology and biobanks — large-scale population studies and biobank-based metabolomics research
- Microbiome and metabolomics — investigating the relationship between the microbiome and metabolic phenotypes
- Nutrition and wellbeing — understanding the metabolic impact of diet and lifestyle factors
- Neurology — metabolomics applications in neurological disease research
- Infectious disease and COVID-19 — metabolic phenotyping in the context of infectious diseases including COVID-19
Community, Quality, and Partnerships
- biocrates supports a global network of certified laboratories and distribution partners to ensure broad accessibility of its metabolomics solutions
- The company maintains a formal quality policy underpinning the reproducibility and standardization of its kit-based workflows
- The Biognosys Group, of which biocrates is now a part, operates with a vendor-neutral strategy and flexible business models to support broad compatibility across mass spectrometry platforms
- Technologies within the group are designed to operate independently or within a unified multiomics ecosystem
- biocrates provides a rich learning ecosystem including scientific presentations, a poster gallery, literature and blog resources, events, a podcast, and a metabolite-of-the-month series
With its vision that everyone can become aware of the connections between health and lifestyle, biocrates is committed to making metabolic phenotyping a cornerstone of disease prevention, well-being maintenance, and quality-of-life improvement — serving researchers and institutions worldwide through its kits, software, services, and global partner network.